(Q71629909)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Induction of autoimmune phenomena in patients with chronic hepatitis B treated with gamma-interferon (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

1 reference

P Weber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

K H Wiedmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

R Klein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

E Walter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

H E Blum

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

P A Berg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 March 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

321-328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

The effect of recombinant alpha-interferon treatment on serum levels of hepatitis B virus-encoded proteins in man.

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Effect of IFN-γ on the immune response in vivo and on gene expression in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Expression of class I and class II major histocompatibility complex antigens on human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Effect of interferon alpha, gamma, and tumor necrosis factor alpha on the HLA-A, B, C expression of cell lines derived from human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Anti-actin antibodies of IgM and IgG class in chronic liver diseases detected by fluorometric immunoassay*

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

The antimitochondrial antibody anti-M9. A marker for the diagnosis of early primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Demonstration of "naturally occurring mitochondrial antibodies" in family members of patients with primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Serological definition of new subgroup of patients with autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Spot-blot hybridization assay for the detection of hepatitis B virus DNA in serum: factors determining its sensitivity and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Combination of recombinant interferons alpha and gamma in treatment of chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Beta- and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Therapy of chronic hepatitis B with recombinant human alpha and gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Recombinant human γ-interferon in patients with chronic active hepatitis B: Pharmacokinetics, tolerance and biological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Clinical toxicity of interferons in cancer patients: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Auto-immune thrombocytopenia related to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Alpha-interferon and immune hemolytic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Interferon-induced aplasia: evidence for T-cell-mediated suppression of hematopoiesis and recovery after treatment with horse antihuman thymocyte globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Membranoproliferative glomerulonephritis in a patient with hairy-cell leukemia treated with alpha-II interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Recombinant alpha 2 interferon-related cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Psoriasis and Raynaud's phenomenon associated with autoantibodies to U1 and U2 small nuclear ribonucleoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Psoriasis and alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Systemic alpha-interferon therapy of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: evidence that HBc-containing hepatocytes may express HLA-DR antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

Suppression of HLA class II expression on thyrocytes by interferon-alpha 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

NIH conference. Systemic lupus erythematosus: insights from animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980002-2

7 January 2021

10.1016/S0168-8278(94)80002-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7516948%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference